Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated cancers

Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated cancers

US Patent 12139523 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bioprinter2025
Heat dissipation assembly for a terminal device2025
Fusion protein of single domain antibody and procoagulant2025
Method for making a perovskite layer at high speed2025
Modular, microfluidic, mechanically active bioreactor for 3D, multi-tissue, tiss2025
Photothermal seawater desalination material with multi-stage structure and prepa2025
Fasteners for security devices2024
Method of preparing high chiral purity lactam intermediate and brivaracetam2024
Alumina-based heterojunction material with abundant oxygen vacancies and prepara2023
Modular, microfluidic, mechanically active bioreactor for 3D, multi-tissue, tiss2023
Highly-reliable multilayer solid aluminum electrolytic capacitor and method for 2023
Sustained delivery formulations of risperidone compound2023